Thanks FTM. Yhe 60% improvement over the Control Arm results is an outstanding number. Of all the Trials shown these results can be classified (STANDALONE) meaningthat compared to the PPHM results all the other Trials were insignificant. In most likelyhood the compromised results with the FDA were probably about20% worse than the actual numbers. Let's say, they were even worse, 60% versus 109% increase in MOS. I do not think this stock will be trading at these levels very long. ALL THE BEST>